QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
one-fifth of one redeemable warrant |
||||
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
☒ | Smaller reporting company | |||||
Emerging growth company |
Page |
||||
1 | ||||
2 | ||||
3 | ||||
4 | ||||
5 | ||||
16 | ||||
19 | ||||
19 | ||||
21 | ||||
22 | ||||
58 | ||||
58 | ||||
58 | ||||
58 | ||||
59 | ||||
60 |
• | We are a recently incorporated company with a limited operating history and no revenues, and you have no basis on which to evaluate our ability to achieve our business objective. |
• | Our public stockholders may not be afforded an opportunity to vote on our proposed initial business combination, which means we may complete our initial business combination even though a majority of our public stockholders do not support such a combination. |
• | If we seek stockholder approval of our initial business combination, our sponsor and our directors, officers and advisors have agreed to vote in favor of such initial business combination, regardless of how our public stockholders vote. |
• | If we seek stockholder approval of our initial business combination and we do not conduct redemptions pursuant to the tender offer rules, and if you or a “group” of stockholders are deemed to hold in excess of 15% of our Class A common stock, you will lose the ability to redeem all such shares in excess of 15% of our Class A common stock. |
• | As the number of special purpose acquisition companies evaluating targets increases, attractive targets may become scarcer and there may be more competition for attractive targets. This could increase the cost of our initial business combination and could even result in our inability to find a target or to consummate an initial business combination. |
• | Changes in the market for directors and officers liability insurance could make it more difficult and more expensive for us to negotiate and complete an initial business combination. |
• | Nasdaq may delist our securities from trading on its exchange, which could limit investors’ ability to make transactions in our securities and subject us to additional trading restrictions. |
• | We previously received a notice of failure to satisfy a continued listing rule from Nasdaq, and while we have since regained compliance with the listing rule, we may in the future fail to comply with applicable Nasdaq rules. |
• | Your only opportunity to affect the investment decision regarding a potential business combination will be limited to the exercise of your right to redeem your shares from us for cash, unless we seek stockholder approval of the initial business combination. |
• | The ability of our public stockholders to redeem their shares for cash may make our financial condition unattractive to potential business combination targets, which may make it difficult for us to enter into an initial business combination with a target. |
• | The ability of our public stockholders to exercise redemption rights with respect to a large number of our shares may not allow us to complete the most desirable business combination or optimize our capital structure. |
• | The ability of our public stockholders to exercise redemption rights with respect to a large number of our shares could increase the probability that our initial business combination would be unsuccessful and that you would have to wait for liquidation in order to redeem your stock. |
• | The requirement that we complete our initial business combination within the prescribed timeframe may give potential target businesses leverage over us in negotiating an initial business combination and may decrease our ability to conduct due diligence on potential business combination targets as we approach our dissolution deadline, which could undermine our ability to complete our initial business combination on terms that would produce value for our stockholders. |
• | We may not be able to complete our initial business combination within the prescribed timeframe, in which case we would cease all operations except for the purpose of winding up and we would redeem our public shares and liquidate, in which case our public stockholders may only receive $10.00 per share, or less than such amount in certain circumstances, and our warrants will expire worthless. |
• | If we seek stockholder approval of our initial business combination, our sponsor, directors, officers, advisors and their affiliates may elect to purchase public shares or warrants from public stockholders, which may influence a vote on a proposed initial business combination and reduce the public “float” of our Class A common stock or warrants. |
• | If a stockholder fails to receive notice of our offer to redeem our public shares in connection with our initial business combination, or fails to comply with the procedures for tendering its shares, such shares may not be redeemed. |
• | Our search for a business combination, and any target business with which we ultimately consummate a business combination, may be materially adversely affected by the ongoing coronavirus (COVID-19) pandemic and the status of debt and equity markets. |
• | You will not have any rights or interests in funds from the trust account, except under certain limited circumstances. To liquidate your investment, therefore, you may be forced to sell your public shares or warrants, potentially at a loss. |
• | You will not be entitled to protections normally afforded to investors of many other blank check companies. |
• | Our warrants are accounted for as liabilities and the changes in value of our warrants could have an adverse effect on the market price of our Class A common stock or make it more difficult for us to consummate an initial business combination. |
• | We have identified a material weakness in our internal control over financial reporting. This material weakness could continue to adversely affect our ability to report our results of operations and financial condition accurately and in a timely manner. |
• | We may face litigation and other risks as a result of the material weakness in our internal control over financial reporting. |
• | Because of our special purpose acquisition company structure and limited resources and the significant competition for business combination opportunities, it may be more difficult for us to complete our initial business combination. If we do not complete our initial business combination, our public stockholders may receive only approximately $10.00 per share on our redemption of our public shares, or less than such amount in certain circumstances, and our warrants will expire worthless. |
• | As the number of special purpose acquisition companies evaluating targets increases, attractive targets may become scarcer and there may be more competition for attractive targets. This could increase the cost of our initial business combination and could even result in our inability to find a target or to consummate an initial business combination. |
September 30, 2021 |
December 31, 2020 |
|||||||
(Unaudited) | ||||||||
ASSETS |
||||||||
Current assets |
||||||||
Cash |
$ | $ | ||||||
Prepaid expenses |
||||||||
|
|
|
|
|||||
Total Current Assets |
||||||||
Deferred offering costs |
||||||||
Marketable securities held in Trust Account |
||||||||
|
|
|
|
|||||
TOTAL ASSETS |
$ |
$ |
||||||
|
|
|
|
|||||
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) |
||||||||
Current liabilities |
||||||||
Accrued expenses |
$ | $ | ||||||
Accrued offering costs |
||||||||
|
|
|
|
|||||
Total Current Liabilities |
||||||||
Warrant Liability |
||||||||
Deferred underwriting fee payable |
||||||||
|
|
|
|
|||||
Total Liabilities |
||||||||
|
|
|
|
|||||
Commitments |
||||||||
Class A common stock subject to possible redemption |
||||||||
Stockholders’ Equity (Deficit) |
||||||||
Preferred stock, $ |
||||||||
Class A common stock, $ |
||||||||
Class B common stock, $ |
||||||||
Additional paid-in capital |
||||||||
Accumulated deficit |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total Stockholders’ Equity (Deficit) |
( |
) |
||||||
|
|
|
|
|||||
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) |
$ |
$ |
||||||
|
|
|
|
Three Months Ended September 30, 2021 |
Nine Months Ended September 30, 2021 |
|||||||
General and administrative expenses |
$ | $ | ||||||
Loss from operations |
( |
) |
( |
) | ||||
Other income (expense): |
||||||||
Interest earned on marketable securities held in Trust Account |
||||||||
Change in fair value of warrant liability |
||||||||
Transaction costs incurred in connection with warrant liabilities |
— | ( |
) | |||||
Compensation expense — warrants |
— | ( |
) | |||||
Other income, net |
||||||||
Net income |
$ |
$ |
||||||
Basic and diluted weighted average shares outstanding, Class A common stock |
||||||||
Basic and diluted net income per share, Class A common stock |
$ |
$ |
||||||
Basic and diluted weighted average shares outstanding, Class B common stock |
||||||||
Basic and diluted net income per share, Class B common stock |
$ |
$ |
||||||
Class A Common Stock |
Class B Common Stock |
Additional Paid-in Capital |
Accumulated Deficit |
Total Stockholders’ Equity (Deficit) |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance—January 1, 2021 |
$ |
$ |
$ |
$ |
( |
) |
$ |
|||||||||||||||||||||
Sale of |
— | — | — | |||||||||||||||||||||||||
Accretion for Class A common stock to redemption amount (1) |
— | — | — | — | ( |
) | ( |
) | ( |
) | ||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
Balance—March 31, 2021 (1) |
( |
) |
( |
) | ||||||||||||||||||||||||
Net income |
— | — | — | — | — | |||||||||||||||||||||||
Balance—June 30, 2021 (1) |
$ |
$ | $ |
( |
) |
$ |
( |
) | ||||||||||||||||||||
Net income |
— | — | — | — | — | |||||||||||||||||||||||
Balance—September 30, 2021 |
$ |
$ | $ |
( |
) |
$ |
( |
) | ||||||||||||||||||||
(1) | As restated for Class A common stock subject to redemption (see Note 2). |
Nine Months Ended September 30, 2021 |
||||
Cash Flows from Operating Activities: |
||||
Net income |
||||
Adjustments to reconcile net income to net cash used in operating activities: |
||||
Interest earned on marketable securities held in Trust Account |
( |
) | ||
Change in fair value of warrant liability |
( |
) | ||
Transaction costs associated with Initial Public Offering |
||||
Compensation expense |
||||
Changes in operating assets and liabilities: |
||||
Prepaid expenses |
( |
) | ||
Accrued expenses |
||||
Net cash used in operating activities |
( |
) | ||
Cash Flows from Investing Activities: |
||||
Investment of cash in Trust Account |
( |
) | ||
Net cash used in investing activities |
( |
) | ||
Cash Flows from Financing Activities: |
||||
Proceeds from sale of Units, net of underwriting discounts paid |
||||
Proceeds from sale of Private Placement Units |
||||
Proceeds from promissory note – related party |
||||
Repayment of promissory note – related party |
( |
) | ||
Payment of offering costs |
( |
) | ||
Net cash provided by financing activities |
||||
Net Change in Cash |
||||
Cash—Beginning of period |
||||
Cash—End of period |
$ |
|||
Supplemental disclosure of non-cash investing and financing activities: |
||||
Offering costs included in accrued offering costs |
$ | |||
Initial classification of Class A common stock subject to possible redemption (1) |
$ | |||
Accretion for initial redemption value |
$ | |||
Deferred underwriting fee payable |
$ | |||
(1) | As restated for Class A common stock subject to redemption |
Balance Sheet as of March 4, 2021 (audited) |
As Previously Reported |
Adjustment |
As Restated |
|||||||||
Common stock subject to possible redemption |
$ | $ | $ | |||||||||
Common stock |
$ | $ | ( |
) | $ | |||||||
Additional paid-in capital |
$ | $ | ( |
) | $ | — | ||||||
Accumulated deficit |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Total Stockholders’ Equity (Deficit) |
$ | $ | ( |
) | $ | ( |
) | |||||
Class A Common stock subject to possible redemption |
||||||||||||
Balance Sheet as of March 31, 2021 |
||||||||||||
Common stock subject to possible redemption |
$ | $ | $ | |||||||||
Common stock |
$ | $ | ( |
) | $ | |||||||
Additional paid-in capital |
$ | $ | ( |
) | $ | |||||||
Accumulated deficit |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Total Shareholders’ Equity (Deficit) |
$ | $ | ( |
) | $ | ( |
) | |||||
Class A Common stock subject to possible redemption |
||||||||||||
Balance Sheet as of June 30, 2021 |
||||||||||||
Class A Common stock subject to possible redemption |
$ | $ | $ | |||||||||
Class A Common stock |
$ | $ | ( |
) | $ | |||||||
Additional paid-in capital |
$ | $ | ( |
) | $ | — | ||||||
Accumulated deficit |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Total Shareholders’ Equity (Deficit) |
$ | $ | ( |
) | $ | ( |
) | |||||
Class A Common stock subject to possible redemption |
||||||||||||
Statement of Operations for the Three Months Ended March 31, 2021 |
||||||||||||
Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption |
( |
) | — | |||||||||
Basic and diluted net income (loss) per share, Class A common stock subject to possible redemption |
$ | — | $ | — | $ | — | ||||||
Basic and diluted weighted average shares outstanding, Non-redeemable common stock |
( |
) | — | |||||||||
Basic and diluted net income (loss) per share, Non-redeemable common stock |
$ | $ | ( |
) | $ | — | ||||||
Weighted average shares outstanding of Class A common stock |
— | |||||||||||
Basic and diluted net income per share, Class A common stock |
$ | — | $ | ( |
) | $ | ( |
) | ||||
Weighted average shares outstanding of Class B common stock |
— | |||||||||||
Basic and diluted net income per share, Class B common stock |
$ | — | $ | ( |
) | $ | ( |
) | ||||
Statement of Operations for the Three Months Ended June 30, 2021 |
||||||||||||
Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption |
( |
) | — | |||||||||
Basic and diluted net income per share, Class A common stock subject to possible redemption |
$ | — | $ | — | $ | — | ||||||
Basic and diluted weighted average shares outstanding, Non-redeemable common stock |
( |
) | — | |||||||||
Basic and diluted net loss (income) per share, Non-redeemable common stock |
$ | $ | ( |
) | $ | — | ||||||
Weighted average shares outstanding of Class A common stock |
— | |||||||||||
Basic and diluted net loss per share, Class A common stock |
$ | — | $ | $ | ||||||||
Weighted average shares outstanding of Class B common stock |
— | |||||||||||
Basic and diluted net loss per share, Class B common stock |
$ | — | $ | $ | ||||||||
Statement of Operations for the Six Months Ended June 30, 2021 |
||||||||||||
Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption |
( |
) | — | |||||||||
Basic and diluted net income per share, Class A common stock subject to possible redemption |
$ | — | $ | — | $ | — | ||||||
Basic and diluted weighted average shares outstanding, Non-redeemable common stock |
( |
) | — | |||||||||
Basic and diluted net income (loss) per share, Non-redeemable common stock |
$ | ( |
) | $ | $ | — | ||||||
Weighted average shares outstanding of Class A common stock |
— | |||||||||||
Basic and diluted net income per share, Class A common stock |
$ | — | $ | ( |
) | $ | ( |
) | ||||
Weighted average shares outstanding of Class B common stock |
— | |||||||||||
Basic and diluted net income per share, Class B common stock |
$ | — | $ | ( |
) | $ | ( |
) | ||||
Statement of Stockholders’ Equity (Deficit) as of March 31, 2021 |
||||||||||||
Sale of |
( |
) | $ | — | ||||||||
Common stock subject to possible redemption |
( |
) | $ | — | ||||||||
Accretion for Class A common stock to redemption amount |
— | ( |
) | $ | ( |
) | ||||||
Total Stockholders’ equity (deficit) |
( |
) | $ | ( |
) | |||||||
Statement of Stockholders’ Equity (Deficit) as of June 30, 2021 |
||||||||||||
Change in value of common stock subject to possible redemption |
$ | $ | ( |
) | $ | — | ||||||
Total Stockholders’ Equity (Deficit) |
$ | $ | ( |
) | $ | ( |
) | |||||
Statement of Cash Flows for the Three Months Ended March 31, 2021 |
||||||||||||
Initial classification of common stock subject to possible redemption |
$ | $ | $ | |||||||||
Change in value of Class A common stock subject to possible redemption |
$ | $ | ( |
) | $ | — | ||||||
Statement of Cash Flows for the Six Months Ended June 30, 2021 |
||||||||||||
Initial classification of common stock subject to possible redemption |
$ | $ | $ | |||||||||
Change in value of Class A common subject to possible redemption |
$ | ( |
) | $ | $ | — |
Gross proceeds |
$ | |||
Less: |
||||
Proceeds allocated to Public Warrants |
$ | ( |
) | |
Class A common stock issuance costs |
( |
) | ||
Plus: |
||||
Accretion of carrying value to redemption value |
$ | |||
Class A common stock subject to possible redemption |
$ | |||
Three Months Ended September 30, 2021 |
Nine Months Ended September 30, 2021 |
|||||||||||||||
Class A |
Class B |
Class A |
Class B |
|||||||||||||
Basic and diluted net income per common stock |
||||||||||||||||
Numerator: |
||||||||||||||||
Allocation of net income, as adjusted |
$ | $ | $ | $ | ||||||||||||
Denominator: |
||||||||||||||||
Basic and diluted weighted average shares outstanding |
||||||||||||||||
Basic and diluted net income per common stock |
$ | $ | $ | $ |
• | Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
• | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
• | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
• | in whole and not in part; |
• | at a price of $ |
• | upon not less than |
• | if, and only if, the closing price of the Class A common stock equals or exceeds $ |
• | in whole and not in part; |
• | at $ |
• | if, and only if, the closing price of our Class A common stock equals or exceeds $ |
Description |
Level |
September 30, 2021 |
||||||||||
Assets: |
||||||||||||
Marketable securities held in Trust Account |
1 | $ | ||||||||||
Liabilities: |
||||||||||||
Warrant Liability – Public Warrants |
1 | $ | ||||||||||
Warrant Liability – Private Placement Warrants |
3 | $ |
Input: |
September 30, 2021 |
March 4, 2021 (Initial Measurement) |
||||||
Risk-free interest rate |
% | % | ||||||
Expected term (years) |
||||||||
Expected volatility |
% | % | ||||||
Exercise price |
$ | $ | ||||||
Fair value of Units |
$ | $ |
Private Placement |
Public |
Warrant Liabilities |
||||||||||
Fair value as of December 31, 2020 |
$ | $ | $ | |||||||||
Initial measurement on March 4, 2021 |
||||||||||||
Change in fair value |
||||||||||||
Fair value as of March 31, 2021 |
||||||||||||
Change in fair value |
( |
) | ( |
) | ( |
) | ||||||
Transfer to Level 1 on June 30, 2021 |
— | ( |
) | ( |
) | |||||||
Fair Value as of June 30, 2021 |
— | |||||||||||
Change in fair value |
( |
) | — | ( |
) | |||||||
Fair value as of September 30, 2021 |
$ | $ | — | $ | ||||||||
• | our ability to select an appropriate target business or businesses; |
• | our ability to complete our initial business combination, particularly given competition from other blank check companies and financial and strategic buyers; |
• | our expectations around the performance of the prospective target business or businesses, including competitive prospects of the business following our initial business combination; |
• | our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination; |
• | our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination; |
• | our potential ability to obtain additional financing to complete our initial business combination; |
• | our pool of prospective target businesses; |
• | our ability to consummate an initial business combination amidst the uncertainty resulting from the ongoing COVID-19 pandemic, the economy and any business or businesses with which we consummate our initial business combination; |
• | the ability of our officers and directors to generate a number of potential acquisition opportunities; |
• | our public securities’ potential liquidity and trading; |
• | the lack of a market for our securities; |
• | our ability to remain in compliance with Nasdaq listing rules; |
• | the use of proceeds not held in the trust account or available to us from interest income on the trust account balance; |
• | the trust account not being subject to claims of third parties; or |
• | our financial performance following this offering. |
• | restrictions on the nature of our investments; and |
• | restrictions on the issuance of securities, each of which may make it difficult for us to complete our initial business combination. |
• | registration as an investment company with the Securities and Exchange Commission; |
• | adoption of a specific form of corporate structure; and |
• | reporting, record keeping, voting, proxy and disclosure requirements and other rules and regulations to which we are currently not subject. |
• | $12.00 per share (as adjusted for stock splits, stock dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period, or the First Price Vesting; |
• | $15.00 per share (as adjusted for stock splits, stock dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period, or the Second Price Vesting; and |
• | $20.00 per share (as adjusted for stock splits, stock dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period, or the Third Price Vesting. |
• | may significantly dilute the equity interest of investors in our initial public offering; |
• | may subordinate the rights of holders of Class A common stock if preferred stock is issued with rights senior to those afforded our Class A common stock; |
• | could cause a change of control if a substantial number of shares of our Class A common stock are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors; |
• | may adversely affect prevailing market prices for our SCALE units, Class A common stock and/or warrants; |
• | may have the effect of delaying or preventing a change of control of us by diluting the share ownership or voting rights of a person seeking to obtain control of us; and |
• | may not result in adjustment to the exercise price of our warrants |
• | default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations; |
• | acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant; |
• | our immediate payment of all principal and accrued interest, if any, if the debt is payable on demand; |
• | our inability to obtain necessary additional financing if the debt contains covenants restricting our ability to obtain such financing while the debt is outstanding; |
• | our inability to pay dividends on our Class A common stock; |
• | using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our Class A common stock if declared, and will reduce our ability to pay expenses, make capital expenditures and acquisitions, and fund other general corporate purposes; |
• | limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate; |
• | increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; |
• | limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, and execution of our strategy; and |
• | other disadvantages compared to our competitors who have less debt. |
• | solely dependent upon the performance of a single business, property or asset, or |
• | dependent upon the development or market acceptance of a single or limited number of products, processes or services. |
• | a limited availability of market quotations for our securities; |
• | reduced liquidity for our securities; |
• | a determination that our Class A common stock is a “penny stock” which will require brokers trading in our Class A common stock to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities; |
• | a limited amount of news and analyst coverage; and |
• | a decreased ability to issue additional securities or obtain additional financing in the future. |
• | the history and prospects of companies whose principal business is the acquisition of other companies; |
• | prior offerings of those companies; |
• | our prospects for acquiring an operating business; |
• | a review of debt to equity ratios in leveraged transactions; |
• | our capital structure; |
• | an assessment of our management and their experience in identifying operating companies; |
• | general conditions of the securities markets at the time of our initial public offering; and |
• | other factors as were deemed relevant. |
• | we have a board that includes a majority of “independent directors,” as defined under the rules of Nasdaq; |
• | we have a compensation committee of our board that is comprised entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities; and |
• | to the extent we have one, we have a nominating and corporate governance committee of our board that is comprised entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities. |
• | higher costs and difficulties inherent in managing cross-border business operations and complying with different commercial and legal requirements of overseas markets; |
• | rules and regulations regarding currency redemption; |
• | complex corporate withholding taxes on individuals; |
• | laws governing the manner in which future business combinations may be effected; |
• | tariffs and trade barriers; |
• | regulations related to customs and import/export matters; |
• | longer payment cycles and challenges in collecting accounts receivable; |
• | tax issues, including but not limited to tax law changes and variations in tax laws as compared to the United States; |
• | currency fluctuations and exchange controls; |
• | rates of inflation; |
• | cultural and language differences; |
• | employment regulations; |
• | data privacy; |
• | changes in industry, regulatory or environmental standards within the jurisdictions where we operate; |
• | public health or safety concerns and governmental restrictions, including those caused by outbreaks of pandemic disease such as the COVID-19 pandemic; |
• | crime, strikes, riots, civil disturbances, terrorist attacks, natural disasters and wars; |
• | deterioration of political relations with the United States; and |
• | government appropriations of assets. |
* | The Certifications attached as Exhibits 32.1 and 32.2 that accompany this Quarterly Report on Form 10-Q are deemed furnished, but not filed, with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of the registrant under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing. |
NIGHTDRAGON ACQUISITION CORP. | ||||||
Date: November 22, 2021 | By: | /s/ Morgan Kyauk | ||||
Name: | Morgan Kyauk | |||||
Title: | Chief Executive Officer (Principal Executive Officer) | |||||
Date: November 22, 2021 | By: | /s/ Steve Simonian | ||||
Name: | Steve Simonian | |||||
Title: | Chief Financial Officer (Principal Financial and Accounting Officer) |